GOLDMAN SACHS GROUP INC - 31 Dec 2024 SCHEDULE 13G/A Report for RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RYTM)

Filing Manager
GOLDMAN SACHS GROUP INC
Reporting Manager
THE GOLDMAN SACHS GROUP, INC.
Security
RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share
Symbol
RYTM
Shares outstanding
60,631,064 shares
Disclosed Ownership
1,818,932 shares
Ownership
3%
Form type
SCHEDULE 13G/A
Filing time
10 Feb 2025, 17:30:28 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"GOLDMAN SACHS GROUP INC disclosed 3% ownership in RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RYTM) on 31 Dec 2024."

Quick Takeaways

  • GOLDMAN SACHS GROUP INC filed SCHEDULE 13G/A for RHYTHM PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RYTM).
  • Disclosed ownership: 3%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 10 Feb 2025, 17:30.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
THE GOLDMAN SACHS GROUP, INC. 3% 1,818,932 0 1,818,787 Name: Sam Prashanth Attorney-in-fact
GOLDMAN SACHS & CO. LLC 3% 1,818,932 0 1,818,787 Name: Sam Prashanth Attorney-in-fact

Sponsored